Table 5.
Items | Treatment 1 | SEM | p-value 2 | |||||
---|---|---|---|---|---|---|---|---|
CON | T1 | T2 | T3 | Treat | Linear | Quadratic | ||
GH | 7.88c | 10.19b | 11.66ab | 12.21a | 0.383 | <0.01 | <0.01 | <0.01 |
IGH-1 | 823.94d | 1066.78c | 1261.15b | 1543.32a | 53.936 | <0.01 | <0.01 | <0.01 |
Leptin | 7.48c | 8.99bc | 9.81b | 11.97a | 0.379 | <0.01 | <0.01 | <0.01 |
IgA | 179.92c | 232.16b | 264.90a | 284.97a | 8.385 | <0.01 | <0.01 | <0.01 |
IgG | 47.92c | 56.28b | 61.97ab | 65.91a | 1.597 | <0.01 | <0.01 | <0.01 |
IgM | 1526.02b | 2210.20a | 2273.15a | 2406.33a | 69.580 | <0.01 | <0.01 | <0.01 |
GH, growth hormone; IGF-1, insulin-like growth factor-1.
Different supplementary levels (CON, control group; T1, 0.1% NSPases/kg DMI; T2, 0.3% NSPases/kg DMI; T3, 0.5% NSPases/kg DMI).
Treat, Linear and Quadratic represent treat, linear, and quadratic effects, respectively, of NSPase supplementation.
a–cValues within a row with different superscripts differ significantly at p < 0.05.